tuftsin has been researched along with ubenimex in 7 studies
| Studies (tuftsin) | Trials (tuftsin) | Recent Studies (post-2010) (tuftsin) | Studies (ubenimex) | Trials (ubenimex) | Recent Studies (post-2010) (ubenimex) |
|---|---|---|---|---|---|
| 534 | 4 | 58 | 930 | 43 | 182 |
| Protein | Taxonomy | tuftsin (IC50) | ubenimex (IC50) |
|---|---|---|---|
| Aminopeptidase B | Rattus norvegicus (Norway rat) | 6 | |
| M1 family aminopeptidase | Plasmodium falciparum FcB1/Columbia | 0.284 | |
| Cytosol aminopeptidase | Bos taurus (cattle) | 1.0005 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 6.45 | |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 1.4742 | |
| Aminopeptidase N | Homo sapiens (human) | 2.6333 | |
| Aminopeptidase N | Sus scrofa (pig) | 3.8211 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 2.7 | |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 3.5 | |
| Bacterial leucyl aminopeptidase | Vibrio proteolyticus | 1.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, V; Diezel, W; Gruner, S; Sönnichsen, N; Volk, HD | 1 |
| Bardana, EJ | 1 |
| Mathé, G | 1 |
| Floc'h, F; Jollès, P; Migliore-Samour, D; Werner, GH | 1 |
| Hadden, JW | 1 |
| Fudenberg, HH; Whitten, HD | 1 |
| Bruley-Rosset, M; Florentin, I; Goutner, A; Mathé, G; Serrou, B | 1 |
5 review(s) available for tuftsin and ubenimex
| Article | Year |
|---|---|
[Immunostimulants--therapeutic aspects].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Humans; Interferon-gamma; Interleukin-2; Leucine; Thymus Hormones; Tuftsin; Tumor Necrosis Factor-alpha | 1989 |
Recent developments in immunomodulatory therapy.
Topics: Adjuvants, Immunologic; Bacterial Vaccines; BCG Vaccine; Bone Marrow Transplantation; Cyclosporins; Fetus; Humans; Immune Sera; Immune Tolerance; Immunization; Immunization, Passive; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Immunotherapy; Injections, Intramuscular; Injections, Intravenous; Inosine Pranobex; Interferons; Leucine; Levamisole; Liver; Major Histocompatibility Complex; Plasma Exchange; Plasmapheresis; Propionibacterium acnes; Thymus Gland; Thymus Hormones; Transfer Factor; Tuftsin | 1985 |
Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Topics: Adjuvants, Immunologic; Animals; Humans; Immunotherapy; Leucine; Neoplasms; Phagocytosis; Tuftsin | 1987 |
Immunomodulating peptides.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antibody Formation; Bacterial Infections; Bacterial Proteins; beta 2-Microglobulin; Chemical Phenomena; Chemistry; Colostrum; Cyclosporins; Fibrinogen; Fungal Proteins; Glycopeptides; Humans; Immunity; Immunity, Cellular; Leucine; Lipoproteins; Macrophages; Milk Proteins; Neoplasms, Experimental; Nerve Tissue Proteins; Peptide Fragments; Peptides; Structure-Activity Relationship; T-Lymphocytes; Thymus Hormones; Tuftsin | 1986 |
Immunostimulation: synthetic and biological modulators of immunity.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Humans; Hypoxanthines; Immunity; Immunization; Immunization, Passive; Immunotherapy; Inosine Pranobex; Interferons; Leucine; Leukocytes; Levamisole; Propionibacterium acnes; Pyran Copolymer; Thymus Hormones; Tuftsin | 1984 |
2 other study(ies) available for tuftsin and ubenimex
| Article | Year |
|---|---|
Chemically defined immunotherapeutic agents.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin | 1983 |
Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Topics: Adjuvants, Immunologic; Animals; Aziridines; Azirines; Cytotoxicity, Immunologic; Drug Evaluation, Preclinical; Immunoglobulin Fragments; Immunotherapy; Leucine; Mice; Neoplasms, Experimental; T-Lymphocytes; Tuftsin | 1982 |